Arguments in favor of remdesivir for treating SARS-CoV-2 infections.

Article Details

Citation

Copy to clipboard

Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR

Arguments in favor of remdesivir for treating SARS-CoV-2 infections.

Int J Antimicrob Agents. 2020 Mar 5:105933. doi: 10.1016/j.ijantimicag.2020.105933.

PubMed ID

32147516 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Remdesivir